ZA963938B - Indole salt. - Google Patents

Indole salt.

Info

Publication number
ZA963938B
ZA963938B ZA9603938A ZA963938A ZA963938B ZA 963938 B ZA963938 B ZA 963938B ZA 9603938 A ZA9603938 A ZA 9603938A ZA 963938 A ZA963938 A ZA 963938A ZA 963938 B ZA963938 B ZA 963938B
Authority
ZA
South Africa
Prior art keywords
indole salt
indole
salt
Prior art date
Application number
ZA9603938A
Other languages
English (en)
Inventor
Martin James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ZA963938B publication Critical patent/ZA963938B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9603938A 1995-05-20 1996-05-17 Indole salt. ZA963938B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent

Publications (1)

Publication Number Publication Date
ZA963938B true ZA963938B (en) 1997-11-17

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603938A ZA963938B (en) 1995-05-20 1996-05-17 Indole salt.

Country Status (42)

Country Link
US (1) US5994387A (zh)
EP (1) EP0827503B1 (zh)
JP (1) JP3233940B2 (zh)
KR (1) KR100295255B1 (zh)
CN (1) CN1063175C (zh)
AP (1) AP738A (zh)
AR (1) AR003949A1 (zh)
AT (1) ATE194986T1 (zh)
AU (1) AU701154B2 (zh)
BG (1) BG63046B1 (zh)
BR (1) BR9610858A (zh)
CA (1) CA2219631C (zh)
CO (1) CO5040221A1 (zh)
CZ (1) CZ287939B6 (zh)
DE (1) DE69609504T2 (zh)
DK (1) DK0827503T3 (zh)
DZ (1) DZ2034A1 (zh)
ES (1) ES2148753T3 (zh)
GB (1) GB9510223D0 (zh)
GR (1) GR3034290T3 (zh)
HK (1) HK1017884A1 (zh)
HR (1) HRP960223B1 (zh)
HU (1) HU217657B (zh)
IL (1) IL118239A (zh)
IS (1) IS1908B (zh)
LV (1) LV11992B (zh)
MA (1) MA23876A1 (zh)
MX (1) MX9708966A (zh)
MY (1) MY132066A (zh)
NO (1) NO312068B1 (zh)
NZ (1) NZ306448A (zh)
OA (1) OA10747A (zh)
PL (1) PL183142B1 (zh)
PT (1) PT827503E (zh)
RU (1) RU2161618C2 (zh)
SK (1) SK281782B6 (zh)
TN (1) TNSN96074A1 (zh)
TR (1) TR199701397T1 (zh)
UA (1) UA44320C2 (zh)
WO (1) WO1996036632A1 (zh)
YU (1) YU29496A (zh)
ZA (1) ZA963938B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (zh) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
IL118239A (en) 2000-10-31
CO5040221A1 (es) 2001-05-29
CZ364897A3 (cs) 1998-11-11
ATE194986T1 (de) 2000-08-15
IS4605A (is) 1997-10-30
CA2219631C (en) 2001-01-23
IS1908B (is) 2003-12-31
CN1063175C (zh) 2001-03-14
BR9610858A (pt) 1999-07-13
ES2148753T3 (es) 2000-10-16
DK0827503T3 (da) 2000-11-20
HRP960223A2 (en) 1997-10-31
LV11992A (lv) 1998-03-20
BG63046B1 (bg) 2001-02-28
NO312068B1 (no) 2002-03-11
HUP9801761A3 (en) 1999-06-28
PT827503E (pt) 2000-11-30
DE69609504D1 (de) 2000-08-31
RU2161618C2 (ru) 2001-01-10
KR19990014934A (ko) 1999-02-25
MA23876A1 (fr) 1996-12-31
WO1996036632A1 (en) 1996-11-21
DE69609504T2 (de) 2000-12-14
NO975210D0 (no) 1997-11-13
CN1185152A (zh) 1998-06-17
DZ2034A1 (fr) 2002-07-21
PL183142B1 (pl) 2002-05-31
CZ287939B6 (cs) 2001-03-14
BG102053A (en) 1998-06-30
HUP9801761A2 (hu) 1999-05-28
YU29496A (sh) 1998-12-23
JP3233940B2 (ja) 2001-12-04
HRP960223B1 (en) 2000-12-31
SK154197A3 (en) 1999-01-11
MX9708966A (es) 1998-03-31
PL323143A1 (en) 1998-03-16
SK281782B6 (sk) 2001-07-10
OA10747A (en) 2002-12-11
AU5500596A (en) 1996-11-29
TNSN96074A1 (fr) 2005-03-15
IL118239A0 (en) 1996-09-12
MY132066A (en) 2007-09-28
GB9510223D0 (en) 1995-07-19
UA44320C2 (uk) 2002-02-15
AU701154B2 (en) 1999-01-21
EP0827503B1 (en) 2000-07-26
HK1017884A1 (en) 1999-12-03
HU217657B (hu) 2000-03-28
AP738A (en) 1999-03-23
NO975210L (no) 1997-11-13
JPH10506639A (ja) 1998-06-30
GR3034290T3 (en) 2000-12-29
TR199701397T1 (xx) 1998-03-21
NZ306448A (en) 1998-10-28
US5994387A (en) 1999-11-30
AP9600801A0 (en) 1996-04-30
CA2219631A1 (en) 1996-11-21
EP0827503A1 (en) 1998-03-11
LV11992B (en) 1998-06-20
KR100295255B1 (ko) 2001-08-07
AR003949A1 (es) 1998-09-30

Similar Documents

Publication Publication Date Title
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA967315B (en) Biphenylamides.
ZA9610858B (en) Heteroclyclic compounds.
ZA967180B (en) Toothbrush.
MX213417B (es) Fenilpiridazinonas.
ZA975689B (en) Phenylalanine derivatives.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA961697B (en) Indole derivatives.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA96750B (en) Toothbrush.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA964560B (en) Anit-viral compounds.
HRP960015B1 (en) Substituted indole derivatives
ZA963938B (en) Indole salt.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA964034B (en) N-aminopyridone derivatives.
ZA967314B (en) Carbamoylcarboxamides.